Nathaniel Sumilang
Aberdeen, MDNPI 1932192754
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 201 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$455
- Pfizer$453
- Merck$393
- Takeda Pharmaceuticals U.S.A., Inc.$360
- Tris Pharma Inc$275
- Supernus Pharmaceuticals, Inc.$198
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,548100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 26 | $455 |
| Pfizer | 36 | $453 |
| Merck | 23 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $360 |
| Tris Pharma Inc | 16 | $275 |
| Supernus Pharmaceuticals, Inc. | 7 | $198 |
| Sanofi Pasteur Inc. | 9 | $182 |
| GSK | 9 | $179 |
| Collegium Pharmaceutical, Inc. | 8 | $153 |
| Johnson & Johnson | 6 | $115 |
| Amgen | 5 | $105 |
| Novo Nordisk | 5 | $104 |
| Seqirus USA Inc | 4 | $75 |
| Shire North American Group Inc | 4 | $69 |
| AstraZeneca | 3 | $59 |
| Bayer | 2 | $54 |
| Adlon Therapeutics L.p. | 3 | $53 |
| Cranial Technologies, Inc | 2 | $42 |
| Exact Sciences | 2 | $34 |
| Medtronic(2 entities) | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| AbbVie | 1 | $28 |
| Neos Therapeutics, LP | 2 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.